NCT01710189View on ClinicalTrials.gov

Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Tick-Borne Encephalitis
Interventions
DRUG

TicoVac

Intramuscular immunisation to right deltoid muscle (Group 1) or right upper anterolateral thigh muscle (Group 2).

Trial Locations (1)

GU2 7XP

Surrey CRC, Egerton Road, Guildford, Surrey

All Listed Sponsors
lead

University of Surrey

OTHER

NCT01710189 - Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac | Biotech Hunter | Biotech Hunter